Dyslipidemia Foundation Inc
Nonprofit profile at a glance
- EIN
- 383936533
- IRS 990-EZ coverage
- 2016–2024
- Forms available
- Form 990-EZ 2024, Form 990-N 2015
- Location
- Natick, MA, USA
- Phone
- 7812581451
- Rating
- 47
- Verdict
- MIXED
- Rating confidence
- Moderate
- Sector
- Specifically Named Diseases
Reported finances
- Revenue
- $193,947
- Expenses
- $175,293
- Assets
- $28,981
- Liabilities
- $0
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Amounts in USD.
Leadership & pay
4 people listed
Executive titles in this filing
- Dr Ernst J Schaefer (President, Treasurer & Dir)
- Bela F Asztalos PhD (Vice President & Director)
People named in this filing
- Peter D Parker (Director)
- Dr Ernst J Schaefer (President, Treasurer & Dir)
- Bela F Asztalos PhD (Vice President & Director)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
1) Provide recognition to healthcare providers and scientists who make significant contributions in the area of the diagnosis and treatment of dyslipidemia. 2) Carry out research related to the management of dyslipidemia to further patient care and CVD risk reduction. 3) Assist patients with significant or severe dyslipidemia in the diagnosis and management of their condition in order to prevent the premature heart disease, stroke, kidney disease, neuropathy, eye disease and recurrent pancreatitis that may occur with these conditions. 4) Provide patients with dyslipidemia and their healthcare providers with education about the diagnosis and management of dyslipidemia through a website, by direct mailing, or with educational programs. 5) Provide patients with dyslipidemia and their healthcare providers with information about experts on dyslipidemia professionals in their geographic area.
What it reported doing in 2024
Participated in conferences, carried out dyslipidemia research, published scientific articles, supported various researchers who make significant contributions to the diagnosis and treatment of dyslipidemia.
Operating model
- Revenue model
- Donor-supported. 100% of the money available for current operations came from contributions and gifts.
- Distribution model
- Cannot be determined from the filing. The filing does not provide enough consistent spending detail to tell whether the nonprofit works directly or through others.
The verdict
MIXED - The filed numbers largely add up and revenue has grown recently. A relatively small share of available resources goes toward mission work and a relatively small share of total spending goes to programs.
Rating breakdown
- Financial Efficiency: 18
- Transparency & Controls: 82
- Sustainability: 48
- Growth: 60
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 17.2%; rating input score 17
- Program expense ratio: 19%; rating input score 19
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 52nd percentile among comparable filings
- Major donor itemization: Limited
Sustainability
- Operating margin: 9.6%; rating input score 57; 57th percentile among comparable filings
- Total-asset coverage ratio: 0.17; rating input score 16; 16th percentile among comparable filings
- Liabilities to assets ratio: 0; rating input score 76; 76th percentile among comparable filings
- Officer compensation ratio: 0%; rating input score 63; 63rd percentile among comparable filings
Growth
- Program expense growth: -10.5% per year; rating input score 0; 14th percentile among comparable filings
- Revenue growth: 7.2% per year; rating input score 100; 57th percentile among comparable filings
- Asset growth: 30% per year; rating input score 100; 88th percentile among comparable filings
Details
- Where the money goes: 17.2% of revenue deployed · 19% of spending went to programs
- Governance: Filed governance answers
- Accomplishments: 1 filed program accomplishment · $33K in reported program spending
- Leadership: top reported pay $0 · 4 people listed
- Consistency: 8 of 9 current checks pass · 1 finding to review
- Schedules: 2 filed schedules
- Filing history: 8 filing years from 2016 to 2024
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Financial Efficiency: Mission deployment rate scored 17/100.
- High — Financial Efficiency: Program expense ratio scored 19/100.
- Moderate — Transparency & Controls: Part III transfer expenses within program total did not reconcile in the filed values.
- High — Growth: Program expense growth scored 0/100.
- High — Sustainability: Total-asset coverage ratio scored 16/100.
- Review — Sustainability: Operating margin scored 57/100.